These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 11744470)

  • 41. Significance of intermittency in men with lower urinary tract symptoms.
    Reynard J; Lim C; Abrams P
    Urology; 1996 Apr; 47(4):491-6. PubMed ID: 8638356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin A injection to the bladder neck and urethra for medically refractory lower urinary tract symptoms in men without prostatic obstruction.
    Chen JL; Chen CY; Kuo HC
    J Formos Med Assoc; 2009 Dec; 108(12):950-6. PubMed ID: 20040460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
    Jiang YH; Wang CC; Kuo HC
    PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstruction.
    Rosier PF; de Wildt MJ; Wijkstra H; Debruyne FF; de la Rosette JJ
    J Urol; 1996 May; 155(5):1649-54. PubMed ID: 8627845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrasound-estimated bladder weight predicts risk of surgery for benign prostatic hyperplasia in men using alpha-adrenoceptor blocker for LUTS.
    Akino H; Maekawa M; Nakai M; Shioyama R; Ishida H; Oyama N; Miwa Y; Yokoyama O
    Urology; 2008 Oct; 72(4):817-20. PubMed ID: 18597835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study.
    Matsukawa Y; Majima T; Matsuo K; Funahashi Y; Kato M; Yamamoto T; Gotoh M
    Int J Urol; 2018 Mar; 25(3):246-250. PubMed ID: 29164680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia.
    Sciarra A; D'Eramo G; Casale P; Loreto A; Buscarini M; Di Nicola S; Seccareccia F; Di Silverio F
    Prostate; 1998 Feb; 34(2):121-8; discussion 129. PubMed ID: 9465943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction.
    Chancellor MB; Rivas DA; Keeley FX; Lotfi MA; Gomella LG
    Br J Urol; 1994 Aug; 74(2):200-3. PubMed ID: 7522872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms.
    Dib PT; Trigo-Rocha F; Gomes CM; Srougi M
    Urol Int; 2008; 80(4):378-82. PubMed ID: 18587248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
    Inamura S; Shinagawa T; Hoshino H; Sakai Y; Imamura Y; Yokoyama O; Kobayashi M
    Prostate; 2017 May; 77(7):794-802. PubMed ID: 28181681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lower urinary tract symptoms, prostate volume and uroflow in norwegian community men.
    Overland GB; Vatten L; Rhodes T; DeMuro C; Jacobsen G; Vada K; Angelsen A; Girman CJ
    Eur Urol; 2001 Jan; 39(1):36-41. PubMed ID: 11173937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
    Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
    Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of transrectal ultrasound measurements of prostate and transition zone size with symptom score, bother score, urinary flow rate, and post-void residual volume.
    Terris MK; Afzal N; Kabalin JN
    Urology; 1998 Sep; 52(3):462-6. PubMed ID: 9730461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia.
    Kwon JK; Han JH; Choi HC; Kang DH; Lee JY; Kim JH; Oh CK; Choi YD; Cho KS
    BJU Int; 2016 Feb; 117(2):316-22. PubMed ID: 25807886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive value of low maximum flow rate in benign prostatic hyperplasia.
    Dorflinger T; Bruskewitz R; Jensen KM; Iversen P; Madsen PO
    Urology; 1986 Jun; 27(6):569-73. PubMed ID: 2424165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Incidence of the form and caliber of urethral resistance. Evaluation for a normal masculine urethra and in cases of obstruction due to prostatic hypertrophy].
    Glémain P; Cordonnier JP; Bochereau G; Baron M; Le Normand L; Buzelin JM
    Prog Urol; 1993 Dec; 3(6):995-1015; discussion 1006-8. PubMed ID: 7508314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The diagnosis of benign prostatic obstruction: Development of a clinical nomogram.
    De Nunzio C; Autorino R; Bachmann A; Briganti A; Carter S; Chun F; Novara G; Sosnowski R; Thiruchelvam N; Tubaro A; Ahyai S;
    Neurourol Urodyn; 2016 Feb; 35(2):235-40. PubMed ID: 25524269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.